Citation Impact
Citing Papers
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Critical review: vegetables and fruit in the prevention of chronic diseases
2012 Standout
Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL or Above
2017
Acute and Longer-Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps: A STAR*D Report
2006 Standout
Algae as nutritional and functional food sources: revisiting our understanding
2016 Standout
Report by the ACNP Task Force on Response and Remission in Major Depressive Disorder
2006
Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial
2008 Standout
Alirocumab in patients with heterozygous familial hypercholesterolaemia undergoing lipoprotein apheresis: the ODYSSEY ESCAPE trial
2016
PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial
2014
Influence of Metabolism on Epigenetics and Disease
2013 StandoutNobel
Meta-analysis of the cholesterol-lowering effect of ezetimibe added to ongoing statin therapy
2007
ESPEN guideline: Clinical nutrition in surgery
2017 Standout
Efficacy and Safety of Alirocumab in Patients with Heterozygous Familial Hypercholesterolemia not Adequately Controlled with Current Lipid-Lowering Therapy: Design and Rationale of the ODYSSEY FH Studies
2014
Genetic influences on blood lipids and cardiovascular disease risk: tools for primary prevention
2009
Effects on Coronary Heart Disease of Increasing Polyunsaturated Fat in Place of Saturated Fat: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
2010 Standout
Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide
2014 Standout
Association Between Omega-3 Fatty Acid Supplementation and Risk of Major Cardiovascular Disease Events
2012
Alternative Dietary Indices Both Strongly Predict Risk of Chronic Disease
2012 Standout
Natural product agonists of peroxisome proliferator-activated receptor gamma (PPARγ): a review
2014 Standout
Colesevelam added to combination therapy with a statin and ezetimibe in patients with familial hypercholesterolemia: A 12-week, multicenter, randomized, double-blind, controlled trial
2010
Amorfrutin B is an efficient natural peroxisome proliferator-activated receptor gamma (PPARγ) agonist with potent glucose-lowering properties
2013
Epidemiology and risk factors for IBD
2015 Standout
Omega-3 Polyunsaturated Fatty Acids and Cardiovascular Diseases
2009 Standout
Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial
2010
Training practitioners to deliver opportunistic multiple behaviour change counselling in primary care: a cluster randomised trial
2013
Lipoprotein-apheresis: Austrian consensus on indication and performance of treatment
2015
Methods of assessment of iodine status in humans: a systematic review
2009 Standout
Omega 3 fatty acids (fish oil) for maintenance of remission in ulcerative colitis
2007
Fish Intake, Contaminants, and Human Health
2006 Standout
Resting Heart Rate in Cardiovascular Disease
2007 Standout
Dietary fat intake and prevention of cardiovascular disease: systematic review
2001
Dietary intervention with oil rich fish reduces platelet-monocyte aggregation in man
2007
n‐3 (omega‐3) polyunsaturated fatty acids prevent acute atrial electrophysiological remodeling
2006
Secondary prevention of CHD in UK men: the Diet and Reinfarction Trial and its sequel
2007
Effects of polyunsaturated fatty acid consumption in diabetic nephropathy
2010
Fish consumption, omega-3 fatty acids and risk of heart failure: A meta-analysis
2012
Omega‐3 Dietary Supplements and the Risk of Cardiovascular Events: A Systematic Review
2009
Postprandial hypertriglyceridemia as a coronary risk factor
2014
Hypertriglyceridemia
2007
Involving patients in cardiovascular risk management with nurse-led clinics: a cluster randomized controlled trial
2009
The differential effects of EPA and DHA on cardiovascular risk factors
2011
Methods of assessment of n–3 long-chain polyunsaturated fatty acid status in humans: a systematic review
2009
Heart Rate, Life Expectancy and the Cardiovascular System: Therapeutic Considerations
2015 Standout
Hypertriglyceridemia: its etiology, effects and treatment
2007
The Severe Hypercholesterolemia Phenotype
2014
Bioavailability and Potential Uses of Vegetarian Sources of Omega-3 Fatty Acids: A Review of the Literature
2013
The Preventable Causes of Death in the United States: Comparative Risk Assessment of Dietary, Lifestyle, and Metabolic Risk Factors
2009 Standout
Dietary lignans: physiology and potential for cardiovascular disease risk reduction
2010 Standout
Association between fish consumption, long chain omega 3 fatty acids, and risk of cerebrovascular disease: systematic review and meta-analysis
2012
Omega-3 Fatty Acids and Cardiovascular Disease
2011
Glycaemic control in type 2 diabetes: Targets and new therapies
2009
Thematic review series: Patient-Oriented Research. Dietary fat, carbohydrate, and protein: effects on plasma lipoprotein patterns
2006
Cardiovascular benefits of omega-3 fatty acids
2006
Essential oils: From extraction to encapsulation
2015 Standout
Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events
2015 Standout
Associations of Omega-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks
2018
Prediction of Cardiovascular Events and All-Cause Mortality With Arterial Stiffness
2010 Standout
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
DNA methylation GrimAge strongly predicts lifespan and healthspan
2019 Standout
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
Pathophysiology of Human Visceral Obesity: An Update
2013 Standout
Oil and Tocopherol Content and Composition of Pumpkin Seed Oil in 12 Cultivars
2007 Standout
Rationale, design, and baseline characteristics for a large international trial of cardiovascular disease prevention in people with dysglycemia: The ORIGIN Trial (Outcome Reduction with an Initial Glargine Intervention)
2007
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Prognosis of Patients With Familial Hypercholesterolemia After Acute Coronary Syndromes
2016
Familial Hypercholesterolemia in the Danish General Population: Prevalence, Coronary Artery Disease, and Cholesterol-Lowering Medication
2012
Safety and Efficacy of Bempedoic Acid to Reduce LDL Cholesterol
2019 Standout
Decision aids for people facing health treatment or screening decisions
2017 Standout
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
2015 Standout
Dietary and Policy Priorities for Cardiovascular Disease, Diabetes, and Obesity
2016 Standout
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
2018 Standout
Long-Term Risk of Atherosclerotic Cardiovascular Disease in US Adults With the Familial Hypercholesterolemia Phenotype
2016
Pathophysiology of Type 2 Diabetes Mellitus
2020 Standout
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Green synthesis of zinc oxide nanoparticles using Hibiscus subdariffa leaf extract: effect of temperature on synthesis, anti-bacterial activity and anti-diabetic activity
2014 Standout
Prevalence of Familial Hypercholesterolemia in the 1999 to 2012 United States National Health and Nutrition Examination Surveys (NHANES)
2016
Evidence Synthesis for Decision Making 2
2012
Food Omega-3 Fatty Acid Intake of Individuals (Total, Linolenic Acid, Long-Chain) and Their Blood Pressure
2007
Plasma Fatty Acid Composition as a Predictor of Arterial Stiffness and Mortality
2009
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
2012
B Vitamin and/or ω-3 Fatty Acid Supplementation and Cancer
2012
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Mechanisms of Diabetic Complications
2013 Standout
Low-Density Lipoprotein Cholesterol–Lowering Effects of AMG 145, a Monoclonal Antibody to Proprotein Convertase Subtilisin/Kexin Type 9 Serine Protease in Patients With Heterozygous Familial Hypercholesterolemia
2012
The Metabolic Syndrome
2008 Standout
Microencapsulation of omega-3 fatty acids: A review of microencapsulation and characterization methods
2014
Effects of Intensive Glucose Lowering in Type 2 Diabetes
2008 Standout
The Controversial Role of Human Gut Lachnospiraceae
2020 Standout
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Omega 3 fatty acids (fish oil) for maintenance of remission in Crohn's disease
2014
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Basal Insulin and Cardiovascular and Other Outcomes in Dysglycemia
2012 Standout
Fish oil for kidney transplant recipients
2016
Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial
2010 Standout
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Works of Nigel Capps being referenced
All-cause and cardiovascular mortality in treated patients with severe hypertriglyceridaemia: A long-term prospective registry study
2010
Total and low-density lipoprotein cholesterol responses to ezetimibe in clinical practice
2006
Reduced or modified dietary fat for preventing cardiovascular disease
2000
Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: a prospective registry study
2008
Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review
2006
Paradoxical HDL‐C reduction during rosiglitazone and fibrate treatment
2007
Diabetes care and the new GMS contract: the evidence for a whole county.
2007
Primary Standardization of Assays for Anticonvulsant Drugs: Comparison of Accuracy and Precision
2002
Omega 3 fatty acids for prevention and treatment of cardiovascular disease
2004